H&H国际控股二零二四年中期报告

公司資料2 財務摘要4 主席報告5 管理層討論及分析11 企業管治及其他資料20 中期簡明綜合財務報表審閱報告35 中期簡明綜合損益及其他全面收益表37 中期簡明綜合財務狀況表38 中期簡明綜合權益變動表40 中期簡明綜合現金流量表42 中期簡明綜合財務報表附註44 公司資料 Laetitia Marie Edmee Jehanne Albertini*Mingshu Zhao Wiggins Cricket SquareHutchins DriveP.O. Box 2681Grand Cayman KY1-1111Cayman Islands 18404007-09 18404007-09 www.hh.global 1 Laetitia AlbertiniPascale Laborde *Laetitia Albertini 97927 Suntera (Cayman) LimitedSuite 3204, Unit 2ABlock 3, Building DP.O. Box 1586Gardenia CourtCamana BayGrand Cayman, KY1–1100Cayman Islands 183171712-1716 財務摘要 *EBITDAEBITDA=EBITDA5.588.446.9 **EBITDA41.488.46.2 (H&H) •166.1% • • • •Solid Gold Great Place to WorkH&H SingaporeCompany of Good 0.30 主席報告 PPAE SwisseSwisseSwisse Plus+SwisseMeLittle Swisse Swisse Plus+48.7%Swisse Plus+Swisse Swisse12.2%78.1%2.1%Swisse23 4Swisse15.6%5Reader’s Digest Trusted BrandsAustralia AwardsSwisseMost Trusted Vitamin BrandSwisse 67 811.7%13.0% 06618 32.0% 113.0%12.2%DHABiostime9 6Nielsen7IMS IQVIA89Kantar Worldpanel 主席報告 40.6%43.7%10 Zesty PawsSolid Gold Zesty PawsCostcoPetco MeijerTargetPetSmart CVS Tractor SupplyZesty Paws Solid GoldZesty PawsSolid Gold18,0004,800 14.8%Solid GoldSolid Gold1110,000 500120235 150168581560 24 Zesty PawsSolid Gold 主席報告 AkashBediAkash BediNick MannBedi BediMann 4.1%4.5%16,692.125.0%66.1% 管理層討論及分析 4,541.410.5%67.9%72.7% 8.8%64.9%Swisse Plus+Swisse Plus+Swisse7.9%4 23.2%2,240.219.0%1,732.4(i)(ii) 500.632.0%DHAKantarBiostime5 14.8%174.3Solid Gold610,00040 16.9%207.314.6%(i)(ii)15.6%7(iii)Swisse8 8.1%12.2% Zesty Paws10.5%CostcoPetco MeijerTargetPetSmart CVS TractorSupply Solid Gold0.5% 5.6% 4,072.34.5%61.1%60.9%(i)Solid Gold(ii) 管理層討論及分析 67.0%64.2% 59.6%62.1% 47.0%46.5%Solid Gold44.347.0%51.0% 118.259.137.56.9 59.1 1.0%2,564.736.4%38.3% 1,208.810.7%37.2%36.9% 29.7%30.0%7.5%6.9% 952.511.9%34.7%39.2% 10.5%12.7%24.2%26.5%(i)(ii) 403.410.3%39.5%41.0% 13.7%12.4%25.8%28.6% 412.41.6%405.95.9%6.1% 161.0104.040.9 22.5%1.2%1.6% 40.9 管理層討論及分析 EBITDAEBITDA EBITDA1,139.813.0%EBITDA18.8%17.0%EBITDA EBITDA1,397.921.4%1,098.4 EBITDAEBITDA EBITDA * (5)Solid Gold EBITDA *10 358.021.0%433.3429.6328.9314.34.6%97.07% 管理層討論及分析 18.9% 295.1218.132.7%41.6%(i)(ii) *10 1,052.51,224.4171.8EBITDA487.0(i)148.7(ii)104.6(iii)52.3(iv)48.6 管理層討論及分析 8.478.68.028.750.0 86.72,040.8400.6428.452.131.91,390.01,406.8 2,429.1 9,503.15,707.2(i)6,987.75,544.6(ii)2,112.7152.1(iii)402.710.4 47.2%46.7%3.423.36 10EBITDA11 1011EBITDA 30603090 22287770 174146157134176168205137 0.3050.0% 168581560,000,000 企業管治及其他資料 C1 C3 3.213.22 企業管治及其他資料 企業管治及其他資料 Laetitia AlbertiniPascaleLabordeLaetitia Albertini (b) (c) (d) (e) (f) Akash Bedi1414A 企業管治及其他資料 6280 13131013104 www.hh.globalIR@hh.global D2 2410 企業管治及其他資料 53,352,0005.625%5.625% 89,500,0007.5%17.9%7.5% (i)(ii) 9.5 64,556,135 64,556,13510% (a)(b) (i)(ii) 10% 1.0% 7.5 企業管治及其他資料 110.50 60,350,34860,230,348 57,808,8948.95% 企業管治及其他資料 1,861,1590.29% 企業管治及其他資料 5,264,5440.82% 571XV352 Coliving LimitedFlying Company Limited100%Coliving LimitedFlying Company Limited UBS Trustees (BVI) LimitedUBS Nominees LimitedFlying Company LimitedSailing Group LimitedSailing Group LimitedColivingLimitedColiving LimitedBiostime Pharmaceuticals (China) Limited 4 5645,561,354 352 企業管治及其他資料 XV23336 Coliving LimitedFlying Company Limited100%Coliving LimitedFlying Company Limited UBS Trustees (BVI) LimitedUBS Nominees LimitedFlying Company LimitedSailing Group LimitedSailing Group LimitedColivingLimitedColiving LimitedBiostime Pharmaceuticals (China) Limited 2645,561,354 XV23336 13.51(2) Biostime Healthy Australia Investment Pty LimitedHealth and Happiness (H&H) USInternational Incorporated1,200,000,000 150,000,000749,735,000 企業管治及其他資料 150,000,000 Biostime Healthy Australia Investment Pty LtdHealth and Happiness (H&H)US International Incorporated(i)(ii)560,000,000 13.2013.2113.22 0.3050.0% 183171712-1716 中期簡明綜合財務報表審閱報告 (H&H) 3780(H&H)343434 2410 中期簡明綜合財務報表審閱報告 34 97927 中期簡明綜合財務報表附註 1. (H&H)Cricket Square,Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands Biostime Pharmaceuticals (China) Limited 2. 34 3 3,489.35,555.0 150.01,090.1560.03,991.0 3. 161177 (a)1616 (b)12 3. (c)77 4. (a)(b)(c)(d)(e) 4. 中期簡明綜合財務報表附註 4. 4. 中期簡明綜合財務報表附註 5. 5. 中期簡明綜合財務報表附註 6. 7. *# 8. 25%25% 15%15%15% 16.5%16.5%2,000,0002,000,0008.25%8.25%16.5%16.5% 中期簡明綜合財務報表附註 8. 30%30% Biostime Healthy Australia Pty Ltd.Biostime Healthy Australia Biostime Healthy Australia Biostime Healthy Australia Biostime Healthy AustraliaBiostime Healthy AustraliaBiostime Healthy Australia 1000Biostime Healthy AustraliaBiostime Healthy AustraliaBiostime Healthy Australia 8. 15% 9. (H&H)0.300.44173,581,000256,700,000 中期簡明綜合財務報表附註 10. 305,803,000608,014,000641,001,009639,704,919 11. 22,029,00026,379,00034,117,00032,773,0002,016,0007,603,0001,799,0003,006,000 12. (a) 12,642